Higher circulating mRNA levels of placental specific genes in a patient with placenta accreta

Prenatal Diagnosis

Volumn 31, Issue 8, 2011, Pages 827-829

  Simonazzi, Giuliana ^a   Farina, Antonio ^a   Curti, Alessandra ^a   Pilu, Gianluigi ^a   Santini, Donatella ^a   Zucchini, Cinzia ^a   Sekizawa, Akihiko ^b   Rizzo, Nicola ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Aberrant mRNA circulating; Maternal blood; Molecular biology; Placenta accreta; Ultrasound

Indexed keywords

COMPLEMENTARY DNA; G PROTEIN COUPLED RECEPTOR 54; GELATINASE B; HUMAN PLACENTA LACTOGEN; KI 67 ANTIGEN; MESSENGER RNA; PLACENTA SPECIFIC 1; PLACENTAL GROWTH FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ADULT; AMNIOCENTESIS; BLOOD SAMPLING; CASE REPORT; CAUCASIAN; CESAREAN SECTION; COLOR ULTRASOUND FLOWMETRY; CONCENTRATION (PARAMETERS); FEMALE; FETUS ECHOGRAPHY; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION; GESTATIONAL AGE; HISTOPATHOLOGY; HUMAN; HYDRAMNIOS; HYSTERECTOMY; IMAGE DISPLAY; LETTER; MATERNAL BLOOD; MICROARRAY ANALYSIS; MYOTONIC DYSTROPHY; PLACENTA ACCRETA; PLACENTA DEVELOPMENT; PLACENTA PREVIA; PREGNANCY COMPLICATION; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION;

ADULT; FEMALE; HUMANS; PLACENTA ACCRETA; PREGNANCY; RNA, MESSENGER;

EID: 79960561285     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2761     Document Type: Letter

References (10)

1. Bilban M, Ghaffari-Tabrizi N, Hintermann E, et al. 2004. Kisspeptin-10, a KiSS-1/metastin-derived decapeptide, is a physiological invasion inhibitor of primary human trophoblasts. J Cell Sci 117(Pt 8): 1319-1328.
2. El Behery MM, Rasha LE, El Alfy Y. 2010. Cell-free placental mRNA in maternal plasma to predict placental invasion in patients with placenta accreta. Int J Gynecol Obstet 109: 30-33.
3. Fant M, Weisoly DL, Cocchia M, et al. 2002. PLAC1, a trophoblast-specific gene, is expressed throughout pregnancy in the human placenta and modulated by keratinocyte growth factor. Mol Reprod Dev 63(4): 430-436.
4. Farina A, Sekizawa A, Purwosunu Y, et al. 2006. Quantitative distribution of a panel of circulating mRNA in preeclampsia versus controls. Prenat Diagn 26(12): 1115-1120.
5. Ke Y, Lu JH, Yang BL, et al. 2006. Involvement of matrix metalloproteinase-2, -9, and tissue inhibitors of metalloproteinase-1, 2 in occurrence of the accrete placenta. Zhonghua Fu Chan Ke Za Zhi 41(5): 311-314.
6. Miura K, Miura S, Yamasaki K, et al. 2008. Increased level of cell-free placental mRNA in a subgroup of placenta previa that needs hysterectomy. Prenat Diagn 28: 805-809.
7. Purwosunu Y, Sekizawa A, Farina A, et al. 2007. Cell-free mRNA concentrations of CRH, PLAC1, and selectin-P are increased in the plasma of pregnant women with preeclampsia. Prenat Diagn 27(8): 772-777.
8. Purwosunu Y, Sekizawa A, Farina A, et al. 2008. Evaluation of physiological alterations of the placenta through analysis of cell-free messenger ribonucleic acid concentrations of angiogenic factors. Am J Obstet Gynecol 198(1): 124.e1-124.e7.
9. Tseng JJ, Chou MM, Hsieh YT, Wen MC, Ho ES, Hsu SL. 2006. Differential expression of vascular endothelial growth factor, placenta growth factor and their receptors in placentae from pregnancies complicated by placenta accreta. Placenta 27(1): 70-78.
10. Tsui NB, Chim SS, Chiu RW, et al. 2004. Systematic micro-array based identification of placental mRNA in maternal plasma: towards non-invasive prenatal gene expression profiling. J MedGenet 41(6): 461-467.